FY2022 Q3 Financial and R&D Update slide image

FY2022 Q3 Financial and R&D Update

ENHERTU® Business Briefing Sunao Manabe President and CEO Date and time 2023 March (TBD) Meeting style Virtual (Zoom) Ken Keller Global Head, Oncology Business Unit Daiichi-Sankyo 16
View entire presentation